Novel adaptation of a running suture technique in a mouse model of corneal transplantation

© 2021 by the author. Licensee POL Scientific, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

HTML

Abstract

Several murine models of corneal transplantation have been developed over the years to study the immunopathological processes that lead to the failure of grafted corneas. In all of them, the classic eight interrupted sutures technique is utilized for transplanting the donor cornea on the host bed. However, in clinical practice, a single continuous suture with a single knot is generally performed for corneal transplantation. Here, we describe the adaptation of the single continuous suture technique in a mouse model of corneal transplantation.

Keywords

animal model

corneal transplantation

running suture technique

References

1. Moffatt SL, Cartwright VA, Stumpf TH. Centennial review of corneal transplantation. Clin Exp Ophthalmol. 2005 Dec;33(6):642–57. https://doi.org/10.1111/j.1442-9071.2005.01134.x PMID:16402960
2. AlMutlak M, Li JY, Bin Helayel H, Fairaq R. Future of Corneal Donation and Transplantation: Insights From the COVID-19 Pandemic. Cornea. 2021 Mar;40(3):274–6. https://doi.org/10.1097/ICO.0000000000002538 PMID:32826649
3. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: a new model. Invest Ophthalmol Vis Sci. 1985 Jan;26(1):23–30. PMID:3881365
4. She SC, Steahly LP, Moticka EJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Ophthalmic Surg. 1990 Nov;21(11):781–5. https://doi.org/10.3928/1542-8877-19901101-08 PMID:2270163
5. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice—evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992 Oct;54(4):694–704. https://doi.org/10.1097/00007890-199210000-00026 PMID:1412761
6. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation. 1997 May;63(10):1501–7. https://doi.org/10.1097/00007890-199705270-00022 PMID:9175817
7. Niederkorn JY. The immune privilege of corneal allografts. Transplantation. 1999 Jun;67(12):1503–8. https://doi.org/10.1097/00007890-199906270-00001 PMID:10401754.
8. Zhang EP, Schründer S, Hoffmann F. Orthotopic corneal transplantation in the mouse—a new surgical technique with minimal endothelial cell loss. Graefe Arch Clin Exp Ophthalmol. 1996 Nov;234(11):714–9. https://doi.org/10.1007/BF00292359. PMID: 8950593.
9. Di Zazzo A, Kheirkhah A, Abud TB, Goyal S, Dana R. Management of high-risk corneal transplantation. Surv Ophthalmol. 2017 Nov - Dec;62(6):816–27. https://doi.org/10.1016/j.survophthal.2016.12.010 PMID:28012874
10. Inomata T, Mashaghi A, Di Zazzo A, Lee SM, Chiang H, Dana R. Kinetics of angiogenic responses in corneal transplantation. Cornea. 2017 Apr;36(4):491–6. https://doi.org/10.1097/ICO.0000000000001127 PMID:28060028
11. Tahvildari M, Dana R. Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases. J Immunol. 2019 Dec;203(11):2749–55. https://doi.org/10.4049/jimmunol.1900733 PMID:31740549
12. Abud TB, Di Zazzo A, Kheirkhah A, Dana R. Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation. J Ophthalmic Vis Res. 2017 Jan-Mar;12(1):81–92. https://doi.org/10.4103/2008-322X.200156 PMID:28299010
13. Tahvildari M, Emami-Naeini P, Omoto M, Mashaghi A, Chauhan SK, Dana R. Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation. Sci Rep. 2017 Apr;7(1):971. https://doi.org/10.1038/s41598-017-01065-z PMID:28428556
14. Inomata T, Mashaghi A, Di Zazzo A, Dana R. Ocular surgical models for immune and angiogenic responses. J Biol Methods. 2015;2(3):e27. https://doi.org/10.14440/jbm.2015.78 PMID:26550579
15. Bachmann BO, Bock F, Wiegand SJ, Maruyama K, Dana MR, Kruse FE, et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol. 2008Jan;126(1):71–7. https://doi.org/10.1001/archopht.126.1.71. PMID: 18195221.
16. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, Armitate WJ; Corneal Transplant Follow-up Study Collaborators. Clinical and surgical factors influencing corneal graft survival, visual acuity, and astigmatism. Ophthalmology. 1996 Jan;103(1):41–9. https://doi.org/10.1016/S0161-6420(96)30734-3 PMID:8628559
17. Vajpayee RB, Sharma V, Sharma N, Panda A, Taylor HR. Evaluation of techniques of single continuous suturing in penetrating keratoplasty. Br J Ophthalmol. 2001 Feb;85(2):134–8. https://doi.org/10.1136/bjo.85.2.134 PMID:11159473
18. McNeill JI, Wessels IF. Adjustment of single continuous suture to control astigmatism after penetrating keratoplasty. Refract Corneal Surg. 1989 Jul-Aug;5(4):216–23. https://doi.org/10.3928/1081-597X-19890701-05 PMID:2488809
19. Plsková J, Kuffová L, Holán V, Filipec M, Forrester JV. Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol. 2002 Jan;86(1):108–13. https://doi.org/10.1136/bjo.86.1.108 PMID:11801514
20. Yamagami S, Tsuru T. Increase in orthotopic murine corneal transplantation rejection rate with anterior synechiae. Invest Ophthalmol Vis Sci. 1999 Sep;40(10):2422–6. PMID:10476812

Previous article in this issue

Next article in this issue

Journal of Biological Methods, Electronic ISSN: 2326-9901 Print ISSN: TBA, Published by POL Scientific

Publisher's Core Philosophy

We are committed to support the scientific community by publishing impactful research and enhancing communication among scientists. At POL Scientific, we are continuously looking for ways to accelerate scientific progress and to strive for transparency and open communication, making knowledge freely accessible without barrier.

171 Skyview St. San Francisco, CA 94131 U.S.A.

info@polscientific.com